A detailed history of Navalign, LLC transactions in Mckesson Corp stock. As of the latest transaction made, Navalign, LLC holds 3,625 shares of MCK stock, worth $2.12 Million. This represents 0.65% of its overall portfolio holdings.

Number of Shares
3,625
Previous 3,803 4.68%
Holding current value
$2.12 Million
Previous $1.76 Million 10.57%
% of portfolio
0.65%
Previous 0.62%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 12, 2024

SELL
$473.42 - $539.26 $84,268 - $95,988
-178 Reduced 4.68%
3,625 $1.95 Million
Q4 2023

Jan 18, 2024

SELL
$437.42 - $470.64 $93,170 - $100,246
-213 Reduced 5.3%
3,803 $1.76 Million
Q3 2023

Oct 10, 2023

BUY
$402.4 - $446.42 $84,504 - $93,748
210 Added 5.52%
4,016 $1.75 Million
Q2 2023

Jul 14, 2023

SELL
$354.01 - $427.31 $23,364 - $28,202
-66 Reduced 1.7%
3,806 $1.63 Million
Q1 2023

Apr 19, 2023

SELL
$335.35 - $386.06 $83,837 - $96,515
-250 Reduced 6.07%
3,872 $1.38 Million
Q4 2022

Feb 06, 2023

SELL
$346.68 - $397.58 $101,923 - $116,888
-294 Reduced 6.66%
4,122 $1.55 Million
Q3 2022

Nov 02, 2022

SELL
$321.25 - $373.84 $71,960 - $83,740
-224 Reduced 4.83%
4,416 $1.5 Million
Q2 2022

Jul 27, 2022

SELL
$300.57 - $336.42 $37,270 - $41,716
-124 Reduced 2.6%
4,640 $1.51 Million
Q1 2022

Apr 29, 2022

SELL
$244.61 - $310.48 $35,713 - $45,330
-146 Reduced 2.97%
4,764 $1.51 Million
Q4 2021

Feb 08, 2022

BUY
$198.21 - $248.9 $4,162 - $5,226
21 Added 0.43%
4,910 $1.22 Million
Q3 2021

Nov 03, 2021

BUY
$188.42 - $208.66 $20,537 - $22,743
109 Added 2.28%
4,889 $975,000
Q2 2021

Aug 13, 2021

BUY
$184.89 - $202.68 $88,377 - $96,881
478 Added 11.11%
4,780 $914,000
Q1 2021

May 10, 2021

BUY
$169.52 - $196.53 $729,275 - $845,472
4,302 New
4,302 $839,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $84.1B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Navalign, LLC Portfolio

Follow Navalign, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Navalign, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Navalign, LLC with notifications on news.